IBDEI2MY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44233,1,3,0)
 ;;=3^Cyst of Prepuce,Benign
 ;;^UTILITY(U,$J,358.3,44233,1,4,0)
 ;;=4^N47.4
 ;;^UTILITY(U,$J,358.3,44233,2)
 ;;=^5015727
 ;;^UTILITY(U,$J,358.3,44234,0)
 ;;=N47.8^^200^2224^25
 ;;^UTILITY(U,$J,358.3,44234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44234,1,3,0)
 ;;=3^Disorders of Prepuce
 ;;^UTILITY(U,$J,358.3,44234,1,4,0)
 ;;=4^N47.8
 ;;^UTILITY(U,$J,358.3,44234,2)
 ;;=^5015730
 ;;^UTILITY(U,$J,358.3,44235,0)
 ;;=N47.7^^200^2224^58
 ;;^UTILITY(U,$J,358.3,44235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44235,1,3,0)
 ;;=3^Inflammatory Diseases of Prepuce
 ;;^UTILITY(U,$J,358.3,44235,1,4,0)
 ;;=4^N47.7
 ;;^UTILITY(U,$J,358.3,44235,2)
 ;;=^5015729
 ;;^UTILITY(U,$J,358.3,44236,0)
 ;;=N47.6^^200^2224^3
 ;;^UTILITY(U,$J,358.3,44236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44236,1,3,0)
 ;;=3^Balanoposthitis
 ;;^UTILITY(U,$J,358.3,44236,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,44236,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,44237,0)
 ;;=N48.1^^200^2224^2
 ;;^UTILITY(U,$J,358.3,44237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44237,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,44237,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,44237,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,44238,0)
 ;;=N52.34^^200^2224^38
 ;;^UTILITY(U,$J,358.3,44238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44238,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,44238,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,44238,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,44239,0)
 ;;=N52.39^^200^2224^40
 ;;^UTILITY(U,$J,358.3,44239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44239,1,3,0)
 ;;=3^Erectile Dysfunction Post-Surgical
 ;;^UTILITY(U,$J,358.3,44239,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,44239,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,44240,0)
 ;;=N52.33^^200^2224^39
 ;;^UTILITY(U,$J,358.3,44240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44240,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,44240,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,44240,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,44241,0)
 ;;=N52.32^^200^2224^36
 ;;^UTILITY(U,$J,358.3,44241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44241,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,44241,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,44241,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,44242,0)
 ;;=N52.31^^200^2224^37
 ;;^UTILITY(U,$J,358.3,44242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44242,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,44242,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,44242,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,44243,0)
 ;;=N52.2^^200^2224^43
 ;;^UTILITY(U,$J,358.3,44243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44243,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,44243,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,44243,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,44244,0)
 ;;=N52.03^^200^2224^34
 ;;^UTILITY(U,$J,358.3,44244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44244,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,44244,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,44244,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,44245,0)
 ;;=N52.02^^200^2224^35
 ;;^UTILITY(U,$J,358.3,44245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44245,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,44245,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,44245,2)
 ;;=^5015753
